NCT06424028

Brief Summary

This Study aims to provide an assessment of clinical presentation, management, hospital course, and prognosis of acute right ventricular infarction presenting with or without Inferior or infero-posterior wall Myocardial Infarction and the assessment of composite adverse clinical outcome after reperfusion in-hospital and post-discharge (in 30 Days Prognosis).

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
1,000

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jan 2024

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 20, 2024

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

May 10, 2024

Completed
11 days until next milestone

First Posted

Study publicly available on registry

May 21, 2024

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 19, 2024

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

August 19, 2024

Completed
Last Updated

May 21, 2024

Status Verified

May 1, 2024

Enrollment Period

6 months

First QC Date

May 10, 2024

Last Update Submit

May 15, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • Composite adverse clinical outcome

    Atleast one adverse event, such as pump failure, cerebrovascular accident (CVA), stent thrombosis, major bleeding, contrast-induced nephropathy (CIN), ventricular arrhythmias, or mortality.

    Upto 30 days from admission

Interventions

Consecutive patients presented with isolated inferior, infero-posterior and inferolateral wall MI with or without acute right ventricular infarction.

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients presented at a tertiary care hospital with Inferior and posterior wall MI with and without RV infarction undergoing PPCI who are fulfilling the eligibility criteria will be enrolled.

You may qualify if:

  • Patients of Inferior, infero-lateral and infero-posterior wall MI with and without RV infarction undergoing PPCI.
  • Both male and female patients.
  • Patients of age ≥ 18 years.

You may not qualify if:

  • Patients who will not give consent for participation.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

National Institute of Cardiovascular Diseases

Karachi, Sindh, 75510, Pakistan

RECRUITING

MeSH Terms

Conditions

Ventricular Dysfunction, Right

Condition Hierarchy (Ancestors)

Ventricular DysfunctionHeart DiseasesCardiovascular Diseases

Study Officials

  • Rajesh Kumar, MBBS, FCPS

    National Institute of Cardiovascular Diaseses

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Rajesh Kumar, MBBS, FCPS

CONTACT

Musa Karim, MSc

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
30 Days
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor Adult Cardiology

Study Record Dates

First Submitted

May 10, 2024

First Posted

May 21, 2024

Study Start

January 20, 2024

Primary Completion

July 19, 2024

Study Completion

August 19, 2024

Last Updated

May 21, 2024

Record last verified: 2024-05

Data Sharing

IPD Sharing
Will not share

The Hospital Medical Record number will be used as the patient identifier.

Locations